The source of information for an expanding, multidisciplinary field

Rapid Science Publishers are delighted to announce the forthcoming launch of Cardiovascular Therapeutics

Cardiovascular Therapeutics has expanded enormously over the past few years. Treatment approaches for cardiovascular disease now encompass a number of factors including drug therapy, nutrition, mechanical devices and innovative operative procedures. Recent advances in molecular biology are leading to innovative treatment modalities, including gene therapy. Technical advances in drug delivery may modify systemic toxicity from drugs by allowing an agent to be delivered to a localized region of the body.

Cardiovascular Therapeutics has become too wide a field to be covered in a pharmacology journal alone. Cardiovascular Therapeutics will be a forum for information now spread across a number of speciality journals. The journal will be essential for all involved in the prevention and treatment of cardiovascular disease.

Cardiovascular Therapeutics will be published 6 times a year by Rapid Science Publishers, London and Philadelphia (an International Thomson Publishing Company).


The journal will publish original papers on all aspects of cardiovascular pharmacology and therapeutics, including:

Additional features will include
  • Reviews in depth (commissioned mini-reviews on topics of major interest)
  • Therapeutic update
  • Therapeutic experience

    Editor in Chief:

    Dr W Frishman
    Professor and Associate Chairman, Dept of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA

    chapman and hall